Healthcare provider profile · identity verified

Trey Van Maanen, MD

Family Practice · HIGHLANDS RANCH, CO · NPI 1093211484

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	400	116
Levothyroxine Sodium	Levothyroxine Sodium	267	68
Lisinopril	Lisinopril	170	55
Losartan Potassium	Losartan Potassium	158	54
Amlodipine Besylate	Amlodipine Besylate	151	49
Simvastatin	Simvastatin	125	34
Rosuvastatin Calcium	Rosuvastatin Calcium	122	38
Tamsulosin Hcl	Tamsulosin Hcl	120	34
Omeprazole	Omeprazole	119	39
Hydrochlorothiazide	Hydrochlorothiazide	107	32
Trazodone Hcl	Trazodone Hcl	100	31
Pantoprazole Sodium	Pantoprazole Sodium	95	29
Allopurinol	Allopurinol	92	26
Metformin Hcl	Metformin Hcl	89	27
Metoprolol Succinate	Metoprolol Succinate	81	27
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	76	20
Synthroid	Levothyroxine Sodium	67	17
Sertraline Hcl	Sertraline Hcl	62	23
Zolpidem Tartrate	Zolpidem Tartrate	61	15
Bupropion Xl	Bupropion Hcl	50	11
Eliquis	Apixaban	47	12
Gabapentin	Gabapentin	40	13
Metoprolol Tartrate	Metoprolol Tartrate	38	11
Montelukast Sodium	Montelukast Sodium	37	11
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	36	suppressed
Finasteride	Finasteride	32	suppressed
Spironolactone	Spironolactone	32	suppressed
Tramadol Hcl	Tramadol Hcl	31	suppressed
Duloxetine Hcl	Duloxetine Hcl	30	suppressed
Meloxicam	Meloxicam	29	11
Warfarin Sodium	Warfarin Sodium	29	suppressed
Potassium Chloride	Potassium Chloride	27	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	26	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	26	suppressed
Pravastatin Sodium	Pravastatin Sodium	26	suppressed
Metformin Hcl Er	Metformin Hcl	25	suppressed
Memantine Hcl	Memantine Hcl	24	suppressed
Tizanidine Hcl	Tizanidine Hcl	24	suppressed
Ozempic	Semaglutide	23	suppressed
Fluticasone Propionate	Fluticasone Propionate	22	suppressed
Torsemide	Torsemide	21	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	20	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	20	11
Fenofibrate	Fenofibrate Nanocrystallized	20	suppressed
Furosemide	Furosemide	20	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	20	suppressed
Jardiance	Empagliflozin	20	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	19	12
Valacyclovir	Valacyclovir Hcl	19	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	19	suppressed
Vyvanse	Lisdexamfetamine Dimesylate	19	suppressed
Colchicine	Colchicine	18	suppressed
Prednisone	Prednisone	18	13
Pregabalin	Pregabalin	18	suppressed
Ezetimibe	Ezetimibe	17	suppressed
Glipizide	Glipizide	17	suppressed
Lacosamide	Lacosamide	17	suppressed
Celecoxib	Celecoxib	16	suppressed
Lansoprazole	Lansoprazole	16	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	16	suppressed
Propranolol Hcl	Propranolol Hcl	16	suppressed
Xarelto	Rivaroxaban	15	suppressed
Alendronate Sodium	Alendronate Sodium	14	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	14	suppressed
Clonazepam	Clonazepam	14	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	14	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	14	suppressed
Clopidogrel	Clopidogrel Bisulfate	13	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	13	suppressed
Diazepam	Diazepam	13	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	13	suppressed
Famotidine	Famotidine	13	suppressed
Valsartan	Valsartan	13	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	12	12
Azithromycin	Azithromycin	12	11
Chlorthalidone	Chlorthalidone	12	suppressed
Mupirocin	Mupirocin	12	suppressed
Paroxetine Hcl	Paroxetine Hcl	12	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	11	suppressed
Fenofibrate	Fenofibrate	11	suppressed
Glipizide Er	Glipizide	11	suppressed
Meclizine Hcl	Meclizine Hcl	11	suppressed
Mounjaro	Tirzepatide	11	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	11	11
Primidone	Primidone	11	suppressed
Sildenafil Citrate	Sildenafil Citrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error